Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. Volume Modulated Arc Therapy

NCT02344667 is registered in ClinicalTrials.gov with Juravinski Cancer Center as lead sponsor.

NCT NCT02344667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02344667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. Volume Modulated Arc Therapy
Lead sponsor
Juravinski Cancer Center
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2015
Completion date
Not reported
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostatic neoplasms